CD276 and renal cell adenocarcinoma: Moreover, in RCC, B7-H3 and B7-H4 were expressed by both immune and endothelial cells: among 743 RCC patients, B7-H3-positive TILs were observed in 17% of tumor samples and in 95% of tumor vasculature [89].